[Publisher's Note: “Special Reports” are posted from time-to-time as a benefit for subscribers and frequent visitors to this blog. “Special Reports” are not widely promoted. To be notified of all new posts, including "Special Reports," please take a moment to subscribe in the right-hand column. Your email address will be kept private.]
Susan G. Komen for the Cure announced a major leadership shake-up earlier this month. Nancy G. Brinker, Komen’s Founder, will step down from the CEO post and move to a new management role focusing on revenue creation, strategy, and global growth as Chair of the Komen Board Executive Committee. Brinker will assume her new position once the search for a new CEO has been completed.
Komen also announced that two board members would be leaving the board and that a nominating process has begun for their replacement.
In a written statement, Brinker said, “Our mission is clear and consistent, and will never change, regardless of the controversy earlier this year. We are doing everything in our power to ensure that women have access to quality cancer care and the support that they need, as we seek answers through cutting-edge research.”
Those interested in reading my analysis of the Komen controversy from earlier this year, can read my post: Does Komen Have a Communications or Integrity Problem?
What do you think of the announcement? Do you think it’s related to the problems earlier in the year?
That’s what Michael Rosen says… What do you say?